Schlappe, B. A., Mueller, J. J., Zivanovic, O., Gardner, G. J., Roche, K. L., Sonoda, Y., . . . O’Cearbhaill, R. E. (2016). Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center. Gynecol Oncol.
Citação norma ChicagoSchlappe, Brooke A., Jennifer J. Mueller, Oliver Zivanovic, Ginger J. Gardner, Kara Long Roche, Yukio Sonoda, Dennis S. Chi, and Roisin E. O’Cearbhaill. "Cited Rationale for Variance in the Use of Primary Intraperitoneal Chemotherapy Following Optimal Cytoreduction for Stage III Ovarian Carcinoma At a High Intraperitoneal Chemotherapy Utilization Center." Gynecol Oncol 2016.
ציטוט MLASchlappe, Brooke A., et al. "Cited Rationale for Variance in the Use of Primary Intraperitoneal Chemotherapy Following Optimal Cytoreduction for Stage III Ovarian Carcinoma At a High Intraperitoneal Chemotherapy Utilization Center." Gynecol Oncol 2016.